Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 29 | $9,889,100 |
Sells | 83 | $3,324,824 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Jun 2024 19:42 | IGMS | IGM Biosciences Inc | SCHWARZER FRED | CEO AND PRESIDENT | 14 Jun 2024 | Sale | 4,164 | 7.5753 | 31,544 | D |
18 Jun 2024 19:43 | IGMS | IGM Biosciences Inc | TAHIR MISBAH | CHIEF FINANCIAL OFFICER | 14 Jun 2024 | Sale | 1,570 | 7.5753 | 11,893 | D |
18 Jun 2024 19:44 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 14 Jun 2024 | Sale | 1,570 | 7.5753 | 11,893 | D |
18 Jun 2024 19:45 | IGMS | IGM Biosciences Inc | WEBER STEVEN | PRINCIPAL ACCOUNTING OFFICER | 14 Jun 2024 | Sale | 495 | 7.5753 | 3,750 | D |
29 Jul 2024 17:45 | IGMS | IGM Biosciences Inc | HAMBLETON JULIE | Director | 25 Jul 2024 | Sale | 15,132 | 14 | 211,848 | D |
17 Sep 2024 20:42 | IGMS | IGM Biosciences Inc | DECKER LISA LYNN | CHIEF BUSINESS OFFICER | 13 Sep 2024 | Sale | 925 | 11.5388 | 10,673 | D |
17 Sep 2024 20:44 | IGMS | IGM Biosciences Inc | HARLER MARY BETH | Head, Research & Autoimmunity | 13 Sep 2024 | Sale | 1,487 | 11.5388 | 17,158 | D |
17 Sep 2024 20:50 | IGMS | IGM Biosciences Inc | KEYT BRUCE | CHIEF SCIENTIFIC OFFICER | 13 Sep 2024 | Sale | 1,487 | 11.5388 | 17,158 | D |
17 Sep 2024 20:52 | IGMS | IGM Biosciences Inc | SCHWARZER FRED | CEO AND PRESIDENT | 13 Sep 2024 | Sale | 3,946 | 11.5388 | 45,532 | D |
17 Sep 2024 20:54 | IGMS | IGM Biosciences Inc | TAHIR MISBAH | CHIEF FINANCIAL OFFICER | 13 Sep 2024 | Sale | 1,487 | 11.5388 | 17,158 | D |
17 Sep 2024 20:55 | IGMS | IGM Biosciences Inc | TAKIMOTO CHRIS H | CHIEF MEDICAL OFFICER | 13 Sep 2024 | Sale | 1,487 | 11.5388 | 17,158 | D |
17 Sep 2024 20:58 | IGMS | IGM Biosciences Inc | WEBER STEVEN | PRINCIPAL ACCOUNTING OFFICER | 13 Sep 2024 | Sale | 469 | 11.5388 | 5,412 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)